Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Free Cash Flow (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Free Cash Flow readings, the most recent being -$10.4 million for Q4 2025.

  • On a quarterly basis, Free Cash Flow fell 43.17% to -$10.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$29.5 million, a 39.53% increase, with the full-year FY2025 number at -$29.5 million, up 39.53% from a year prior.
  • Free Cash Flow hit -$10.4 million in Q4 2025 for Treace Medical Concepts, up from -$11.9 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $655000.0 in Q1 2025 to a low of -$18.7 million in Q1 2023.
  • Median Free Cash Flow over the past 5 years was -$10.3 million (2021), compared with a mean of -$9.5 million.
  • Biggest five-year swings in Free Cash Flow: tumbled 1363.42% in 2022 and later surged 105.88% in 2025.
  • Treace Medical Concepts' Free Cash Flow stood at -$4.7 million in 2021, then crashed by 63.86% to -$7.7 million in 2022, then skyrocketed by 77.69% to -$1.7 million in 2023, then crashed by 324.3% to -$7.3 million in 2024, then plummeted by 43.17% to -$10.4 million in 2025.
  • The last three reported values for Free Cash Flow were -$10.4 million (Q4 2025), -$11.9 million (Q3 2025), and -$7.8 million (Q2 2025) per Business Quant data.